CD BioSciences Launches Metabolic Signaling Pathways for Research Use

CD BioSciences, a US-based life science research product supplier and CRO, recently introduces a comprehensive panel of metabolic signaling pathways to the life science community for research uses, such as insulin signaling pathway, mTOR pathway, and AMPK pathway.

Metabolism describes the life-sustaining chemical reactions in an organism. It can be divided into two categories: catabolism, the breakdown of molecules, and anabolism, the synthesis of molecules. Metabolism is closely related to the availability of nutrients such as proteins, lipids and carbohydrates. The purpose of metabolism is to convert nutrients into energy and building blocks, and to eliminate nitrogenous wastes. Metabolic processes are tightly controlled by cellular signaling pathways to maintain the metabolic homeostasis of the system. Changes in metabolic patterns are one of the hallmarks of cancer.

A metabolic pathway is a series of metabolic chemical reactions catalyzed by a series of enzymes. However, metabolic signaling pathways refer to cellular signaling that respond to metabolic states and regulate cellular events to maintain cellular and organismal homeostasis. Dysregulation of these pathways is associated with obesity, type 2 diabetes, and metabolic diseases such as cancer and aging.

As a trusted CRO, CD BioSciences offers a comprehensive solutions panel covering all aspects of life science research, including metabolism. Now a series of metabolic signaling pathways are available at CD BioSciences for scientific applications, including insulin signaling pathways, mTOR pathways, and AMPK pathways.

Specifically, the insulin signaling pathway is a signal transduction that regulates glucose homeostasis by controlling glucose and lipid metabolism. When pancreatic beta cells release insulin in response to elevated nutrient levels, it binds to insulin receptors, activating signal transduction and leading to cellular processes that promote glucose, fatty acid, and amino acid uptake.

In terms of 5' AMP-activated protein kinase, or AMPK, it plays a central role in cellular energy homeostasis. It is activated when cellular energy levels are low to facilitate the absorption and oxidation of glucose and fatty acids. AMPK regulates cellular events, including cell growth, metabolic reprogramming, and autophagy. AMPK has emerged as a potential therapeutic target for metabolic diseases such as type 2 diabetes and cancer. The first-line drug for type 2 diabetes, metformin, is a potent activator of AMPK and also shows great potential for cancer therapy.

"With decades of experience in signaling pathway solutions for a broad range of applications, our team has built long-standing customer relationships with our clients in science research industry. Designed to cover all aspects of signaling pathway research, our solutions are developed and processed to the highest standards. We're dedicated to meeting all of your signaling pathway research needs, and guarantee on-time delivery of our products and results." said Kristy J. Morris, the marketing director at CD BioSciences.

Customers for more information about metabolic signaling pathways, please visit CD BioSciences at https://www.cd-biosciences.com.

CD BioSciences
New York

About CD BioSciences

info@cd-biosciences.net

CD BioSciences is a trusted research product supplier and CRO based in New York. With high-quality reagents and comprehensive services, CD BioSciences is the one-stop shop devoted to researchers making advancements in signaling pathway studies.

This release was published on openPR.